Results for “”

Entry Author Date Location
Intel Reveals Ideas on Promoting AI in U.S. as Chinese Growth Looms 03/06/19 San Francisco
A Glimpse of A.I.’s Future? MIT-IBM Research Lab Sees Early Progress 03/06/19 Boston
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Retailers Turn to Analytics, 3D Tech to Promote Fit, Reduce Returns 03/04/19 National
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar 03/04/19 Boston
Privacy Watch: FTC, Facebook, EU, the Cloud Act, & More CA bills 03/04/19 San Francisco
SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future 03/01/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington 02/27/19 New York
Walmart’s Store No 8 Acquires Aspectiva to Bring A.I. to Shopping 02/27/19 National
Amazon, Google, Facebook Boosted 2018 Tech Hiring Spree in U.S. Hubs 02/27/19 National
Blackstone, Novartis Start Up Anthos With $250M and a Heart Drug 02/27/19 Boston
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away 02/26/19 National
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer 02/26/19 New York
Oyster Point Gets $93M To Clear Up Dry Eye With a Nasal Spray 02/26/19 New York
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Merck Scooping Up Cancer Drug Developer Immune Design for $300M 02/21/19 New York
Starboard Ups Bristol-Myers Stake Ahead of Vote on Celgene Deal 02/20/19 New York
With New Data, Intercept On Track for First-Ever Approved NASH Drug 02/19/19 New York
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More 02/15/19 National
Finding True Love Can Be Ruff, But This Startup Could Have Your Match 02/14/19 National
It’s Not You, It’s Your Officials: Amazon Cancels HQ Plan for NYC 02/14/19 New York
Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again 02/14/19 National
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B 02/13/19 New York
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans 02/12/19 National
Neurogene Emerges with $68M to Advance Gene Therapies to the Clinic 02/12/19 New York
Matching Amgen, Regeneron to Cut List Price of Heart Drug by 60% 02/11/19 New York
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
With Its First Human Data, Solid Slips in Duchenne Gene Therapy Race 02/07/19 Boston
NYCEDC Finally Puts Its NY Bio Fund to Work With $60M For HiberCell 02/07/19 New York
Page 3 of 82 « previous page · next page »